| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/EXCR.2001.5316 |
| P698 | PubMed publication ID | 11570816 |
| P2093 | author name string | Bartfai T | |
| Langel U | |||
| Lindgren M | |||
| Elmquist A | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 237-244 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Experimental Cell Research | Q1524289 |
| P1476 | title | VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions | |
| P478 | volume | 269 |
| Q35612443 | A Heparan Sulfate-Binding Cell Penetrating Peptide for Tumor Targeting and Migration Inhibition. |
| Q28533791 | A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells |
| Q41537062 | A novel chimeric peptide with antimicrobial activity |
| Q30847307 | A retro-inverso cell-penetrating peptide for siRNA delivery. |
| Q31004655 | A structural basis for cellular uptake of GST-fold proteins |
| Q39466239 | Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs |
| Q37845172 | Antimicrobial peptides with cell-penetrating peptide properties and vice versa |
| Q38166533 | Applications of cell-penetrating peptides for tumor targeting and future cancer therapies. |
| Q38133156 | Applying horizontal gene transfer phenomena to enhance non-viral gene therapy |
| Q36299512 | Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides |
| Q38974301 | Building Cell Selectivity into CPP-Mediated Strategies |
| Q37857282 | Calpain inhibitors: a survey of compounds reported in the patent and scientific literature |
| Q35691164 | Cancer cell surface induced peptide folding allows intracellular translocation of drug |
| Q57188342 | Cell membrane translocation of the N-terminal (1-28) part of the prion protein |
| Q38472405 | Cell penetrating peptides can exert biological activity: a review |
| Q52719303 | Cell penetrating peptides: a comparative transport analysis for 474 sequence motifs. |
| Q35806512 | Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo |
| Q36870925 | Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei |
| Q38881439 | Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals |
| Q37594526 | Cell-penetrating peptides: achievements and challenges in application for cancer treatment |
| Q26800103 | Cell-type specific penetrating peptides: therapeutic promises and challenges |
| Q28535219 | Chemical-functional diversity in cell-penetrating peptides |
| Q47810720 | Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP. |
| Q33231239 | D-TAT transporter as an ocular peptide delivery system |
| Q90731539 | Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties |
| Q38413685 | Development of protein mimics for intracellular delivery |
| Q50218239 | Effect of a Flexible Linker on Recombinant Expression of Cell-Penetrating Peptide Fusion Proteins and Their Translocation into Fungal Cells. |
| Q46783831 | Effective penetration of cell-permeable peptide mimic of tyrosine residue 654 domain of beta-catenin into human renal tubular epithelial cells |
| Q38962523 | Electroporation-based delivery of cell-penetrating peptide conjugates of peptide nucleic acids for antisense inhibition of intracellular bacteria |
| Q88611552 | Emerging Methods and Design Principles for Cell-Penetrant Peptides |
| Q34628862 | Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation |
| Q33574252 | Gene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs |
| Q37036638 | Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection |
| Q42260299 | Impairment of GABAB receptor dimer by endogenous 14-3-3ζ in chronic pain conditions |
| Q44090492 | Increased Hydrophobic Block Length of PTDMs Promotes Protein Internalization |
| Q38942603 | Insights into membrane translocation of the cell-penetrating peptide pVEC from molecular dynamics calculations. |
| Q24655939 | Internalization of cationic peptides: the road less (or more?) traveled |
| Q37710990 | Intracellular transduction using cell-penetrating peptides |
| Q90375954 | Library screening of cell-penetrating peptide for BY-2 cells, leaves of Arabidopsis, tobacco, tomato, poplar, and rice callus |
| Q21296784 | Mechanisms of cellular uptake of cell-penetrating peptides |
| Q37995554 | Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery |
| Q58717273 | Membrane Active Peptides and Their Biophysical Characterization |
| Q38307801 | Membrane-active peptides from marine organisms--antimicrobials, cell-penetrating peptides and peptide toxins: applications and prospects |
| Q33347477 | Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures |
| Q31078024 | Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58) |
| Q38369494 | Modifications of natural peptides for nanoparticle and drug design |
| Q35642174 | Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability |
| Q38165639 | Nanopreparations for organelle-specific delivery in cancer |
| Q34099855 | New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries |
| Q38980476 | Non-viral nucleic acid delivery methods |
| Q41816894 | Passage of cell-penetrating peptides across a human epithelial cell layer in vitro |
| Q33216999 | Peptide aptamers: recent developments for cancer therapy |
| Q37572760 | Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics. |
| Q36202697 | Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake |
| Q92545193 | RNAi therapeutic strategies for acute respiratory distress syndrome |
| Q64122672 | Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies |
| Q37714025 | Silk-based delivery systems of bioactive molecules. |
| Q59662712 | Studying the uptake of cell-penetrating peptides |
| Q91932987 | Targeting Hidden Pathogens: Cell-Penetrating Enzybiotics Eradicate Intracellular Drug-Resistant Staphylococcus aureus |
| Q38974209 | Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy. |
| Q38552370 | The Antimicrobial and Antiviral Applications of Cell-Penetrating Peptides. |
| Q52450404 | The Current Role of Cell-Penetrating Peptides in Cancer Therapy. |
| Q35667863 | The J-domain of heat shock protein 40 can enhance the transduction efficiency of arginine-rich cell-penetrating peptides |
| Q38340819 | The Pharmacokinetics of Cell-Penetrating Peptides |
| Q48118024 | The effect of a beta-lactamase inhibitor peptide on bacterial membrane structure and integrity: a comparative study |
| Q42253045 | The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders. |
| Q34308241 | Transduction peptides: from technology to physiology |
| Q44597076 | Translocation of cell penetrating peptides on Chlamydomonas reinhardtii |
| Q33418436 | Translocation of cell-penetrating peptides and delivery of their cargoes in triticale microspores |
| Q46359263 | Translocation of cell-penetrating peptides into Candida fungal pathogens |
| Q30840924 | Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Docking Study. |
| Q36845812 | Triple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureus |
| Q37230918 | Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics |
| Q60923739 | Versatility of cell-penetrating peptides for intracellular delivery of siRNA |
| Q37340596 | pHLIP-mediated translocation of membrane-impermeable molecules into cells. |
Search more.